Methylenedioxycathinone
chemical compound
3,4-Methylenedioxycathinone (MDC, MDCATH), also known as β-keto-3,4-methylenedioxyamphetamine (β-keto-MDA or βk-MDA), is an entactogen and stimulant drug of the phenethylamine, amphetamine, and cathinone families related to methylone (βk-MDMA or MDMC). It is the β-keto analogue of MDA.
Like methylone, MDC is a serotonin–norepinephrine–dopamine releasing agent (SNDRA). In contrast to MDA and MDMA, MDC shows no activity at the serotonin 5-HT2 receptors, but does retain much weaker affinity for the rodent trace amine-associated receptor 1 (TAAR1).
The drug was patented as an antidepressant and antiparkinsonian agent by Peyton Jacob III and Alexander Shulgin in 1996. MDC and other non-N-substituted cathinones such as cathinone itself are chemically unstable due rapidly forming biologically inactive dimers and this has limited their prevalence.
“Methylenedioxycathinone” enters the record as chemical compound. Crown Archives preserves that source wording while asking what Methylenedioxycathinone, chemical and compound can confirm, complicate or overturn.
Why this record matters
“Methylenedioxycathinone” is worth following because a concise public description often conceals a longer documentary argument. Here, Methylenedioxycathinone, chemical and compound provides the most credible route into that argument.
Stable identifiers, scientific names and standards terminology offer the best bridge between this overview and specialist evidence. The source revision retrieved here is dated Mar 1, 2026. The linked authority identifier is Q6823978. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1996.
A general summary may omit uncertainty, sample limits or methodological disagreement that is explicit in the technical record. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.
- Current terminology
- Classification context
- Finding cited technical literature
Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.
Three-step research path
- Establish the record: confirm the title “Methylenedioxycathinone”, its source revision and the description used here.
- Expand the search: follow Methylenedioxycathinone primary sources, Methylenedioxycathinone archive and Methylenedioxycathinone research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Methylenedioxycathinone”?
- Is the terminology current, historical or disputed?
- Has classification or technical consensus changed since the cited source?
Search terms from this dossier
This entry incorporates text from “Methylenedioxycathinone” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.